Back to search

Sofosbuvir in Treatment of COVID 19

NCT04460443

PHASE2|PHASE3INTERVENTIONAL
Tanta University
60 participants
Started 2020-08-01 · Completed 2021-08-31
Status: Unknown (as of 12-23-2025)

Conditions

COVID

Interventions

DRUG: sofosbuvirDRUG: Sofosbuvir ledipsavirDRUG: Daclatasvir

Linked Papers (from SciSciNet-V2)

Total Papers0
Background
0
Result
0
Derived
0
Unknown
0
View on ClinicalTrials.gov

Brief Summary

Sofosbuvir containing treatment in treatment of COVID 19 Egyptian patients

No papers linked to this trial in SciSciNet

Visit ClinicalTrials.gov for more information about this study